CSL Ltd

Common Name

CSL

Country

Australia

Sector

Healthcare

Industry

Biotechnology

Employees

32,698

Ticker

CSL

Exchange

ASX

Website

www.csl.com

Description

CSL Limited is a leading biotechnology company specializing in the research, development, manufacturing, and marketing of innovative biopharmaceutical products. The company's core activities focus on ... Show more

Financial Statements of CSL

Below are the financial statements of CSL, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	1,657^a	1,548^a
Receivables and contract assets	2,895^a	2,214^a
Inventories	5,964^a	5,466^a
Current tax assets	126^a	31^a
Assets held for sale	126^a	0^a
Total current assets	10,768^a	9,259^a
Non-current assets	—	—
Property, plant and equipment	8,148^a	7,797^a
Right-of-use assets	1,510^a	1,555^a
Intangible assets	16,346^a	16,446^a
Deferred tax assets	911^a	902^a
Retirement benefit assets	18^a	6^a
Other financial assets	163^a	173^a
Other non-current assets	158^a	96^a
Total non-current assets	27,254^a	26,975^a
Total assets	38,022^a	36,234^a
Current liabilities	—	—
Trade and other payables	3,345^a	2,947^a
Interest-bearing liabilities and borrowings	944^a	1,055^a
Current tax liabilities	176^a	296^a
Provisions	475^a	310^a
Liabilities held for sale	10^a	0^a
Total current liabilities	4,950^a	4,608^a
Non-current liabilities	—	—
Interest-bearing liabilities and borrowings	11,239^a	11,172^a
Retirement benefit liabilities	282^a	204^a
Deferred tax liabilities	1,514^a	1,464^a
Provisions	186^a	467^a
Other non-current liabilities	450^a	493^a
Total non-current liabilities	13,671^a	13,800^a
Total liabilities	18,621^a	18,408^a
Net assets	19,401^a	17,826^a
Equity	—	—
Contributed equity	557^a	517^a
Reserves	794^a	648^a
Retained earnings	16,012^a	14,621^a
Equity attributable to shareholders of CSL Limited	17,363^a	15,786^a
Non-controlling interests	2,038^a	2,040^a
Total equity	19,401^a	17,826^a

Download Data

Verified Sources Behind CSL’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CSL’s data sources below and access millions more through our Disclosure Search.

a. CSL's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

CSL Ltd

Financial Statements of CSL

Verified Sources Behind CSL’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Ucb SA

Insmed Inc

Blueprint Medicines Corp

Zealand Pharma A/S

BioMarin Pharmaceutical Inc

Verona Pharma PLC